<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32188741</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1754-8411</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Disease models &amp; mechanisms</Title><ISOAbbreviation>Dis Model Mech</ISOAbbreviation></Journal><ArticleTitle>The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmm043513</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dmm.043513</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects both lower and upper motor neurons (MNs) in the central nervous system. ALS etiology is highly multifactorial and multifarious, and an effective treatment is still lacking. Neuroinflammation is a hallmark of ALS and could be targeted to develop new therapeutic approaches. Interestingly, the transcription factor Nurr1 has been demonstrated to have an important role in the inflammatory process in several neurological disorders, such as Parkinson's disease and multiple sclerosis. In the present paper, we demonstrate for the first time that Nurr1 expression levels are upregulated in the peripheral blood of ALS patients. Moreover, we investigated Nurr1 function in the SOD1-G93A mouse model of ALS. Nurr1 was strongly upregulated in the spinal cord during the asymptomatic and early symptomatic phases of the disease, where it promoted the expression of brain-derived neurotrophic factor mRNA and the repression of NF&#x3ba;B pro-inflammatory targets, such as inducible nitric oxide synthase. Therefore, we hypothesize that Nurr1 is activated in an early phase of the disease as a protective endogenous anti-inflammatory mechanism, although not sufficient to reverse disease progression. On the basis of these observations, Nurr1 could represent a potential biomarker for ALS and a promising target for future therapies.</AbstractText><CopyrightInformation>&#xa9; 2020. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0514-8579</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10126 Turin, Italy valsecchiv@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Reproductive and Dentistry Sciences, University of Naples "Federico II", via S. Pansini 5, 80131, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boido</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montarolo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology Unit, Neurology - CReSM (Regional Referring Center of Multiple Sclerosis), AOU San Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guglielmotto</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perga</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology Unit, Neurology - CReSM (Regional Referring Center of Multiple Sclerosis), AOU San Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martire</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6889-888X</Identifier><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology Unit, Neurology - CReSM (Regional Referring Center of Multiple Sclerosis), AOU San Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cutrupi</LastName><ForeName>Santina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannello</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8940-1406</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gionchiglia</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Signorino</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, Amyotrophic Lateral Sclerosis Expert Center (CRESLA), University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Citt&#xe0; della Scienza e della Salute, corso Bramante 88, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuda</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, Amyotrophic Lateral Sclerosis Expert Center (CRESLA), University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Citt&#xe0; della Scienza e della Salute, corso Bramante 88, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, Amyotrophic Lateral Sclerosis Expert Center (CRESLA), University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Citt&#xe0; della Scienza e della Salute, corso Bramante 88, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolotto</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7052-1907</Identifier><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology Unit, Neurology - CReSM (Regional Referring Center of Multiple Sclerosis), AOU San Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercelli</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dis Model Mech</MedlineTA><NlmUniqueID>101483332</NlmUniqueID><ISSNLinking>1754-8403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057126">Nuclear Receptor Subfamily 4, Group A, Member 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057126" MajorTopicYN="N">Nuclear Receptor Subfamily 4, Group A, Member 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Nurr1</Keyword><Keyword MajorTopicYN="N">SOD1-G93A mice</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32188741</ArticleId><ArticleId IdType="pmc">PMC7240304</ArticleId><ArticleId IdType="doi">10.1242/dmm.043513</ArticleId><ArticleId IdType="pii">dmm.043513</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aarnisalo P., Kim C.-H., Lee J. W. and Perlmann T. (2002). Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1. J. Biol. Chem. 277, 35118-35123. 10.1074/jbc.M201707200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M201707200</ArticleId><ArticleId IdType="pubmed">12130634</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Castelao B., Losada F., Ahicart P. and Casta&#xf1;o J. G. (2013). The N-terminal region of Nurr1 (a.a 1-31) is essential for its efficient degradation by the ubiquitin proteasome pathway. PLoS ONE 8, e55999 10.1371/journal.pone.0055999</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055999</ArticleId><ArticleId IdType="pmc">PMC3567022</ArticleId><ArticleId IdType="pubmed">23409108</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzilotti S., Brancaccio P., Simeone G., Valsecchi V., Vinciguerra A., Secondo A., Petrozziello T., Guida N., Sirabella R., Cuomo O. et al. (2018). Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na. Cell Death Dis. 9, 206 10.1038/s41419-017-0227-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0227-9</ArticleId><ArticleId IdType="pmc">PMC5833681</ArticleId><ArticleId IdType="pubmed">29434186</ArticleId></ArticleIdList></Reference><Reference><Citation>Barneda-Zahonero B., Servitja J.-M., Badiola N., Mi&#xf1;ano-Molina A. J., Fad&#xf3; R., Saura C. A. and Rodr&#xed;guez-Alvarez J. (2012). Nurr1 protein is required for N-methyl-D-aspartic acid (NMDA) receptor-mediated neuronal survival. J. Biol. Chem. 287, 11351-11362. 10.1074/jbc.M111.272427</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.272427</ArticleId><ArticleId IdType="pmc">PMC3322860</ArticleId><ArticleId IdType="pubmed">22294685</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron O., F&#xf6;rthmann B., Lee Y.-W., Terranova C., Ratzka A., Stachowiak E. K., Grothe C., Claus P. and Stachowiak M. K. (2012). Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons. J. Biol. Chem. 287, 19827-19840. 10.1074/jbc.M112.347831</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.347831</ArticleId><ArticleId IdType="pmc">PMC3370168</ArticleId><ArticleId IdType="pubmed">22514272</ArticleId></ArticleIdList></Reference><Reference><Citation>Boido M., Piras A., Valsecchi V., Spigolon G., Mareschi K., Ferrero I., Vizzini A., Temi S., Mazzini L., Fagioli F. et al. (2014). Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. Cytotherapy 16, 1059-1072. 10.1016/j.jcyt.2014.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2014.02.003</ArticleId><ArticleId IdType="pubmed">24794182</ArticleId></ArticleIdList></Reference><Reference><Citation>Boido M., De Amicis E., Valsecchi V., Trevisan M., Ala U., Ruegg M. A., Hettwer S. and Vercelli A. (2018). Increasing agrin function antagonizes muscle atrophy and motor impairment in spinal muscular atrophy. Front. Cell Neurosci. 12, 17 10.3389/fncel.2018.00017</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00017</ArticleId><ArticleId IdType="pmc">PMC5797594</ArticleId><ArticleId IdType="pubmed">29440993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonta P. I., Van Tiel C. M., Vos M., Pols T. W. H., Van Thienen J. V., Ferreira V., Arkenbout E. K., Seppen J., Spek C. A., Van Der Poll T. et al. (2006). Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 26, 2288-294. 10.1161/01.ATV.0000238346.84458.5d</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000238346.84458.5d</ArticleId><ArticleId IdType="pubmed">16873729</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A. and Traynor B. J. (2018). Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 17, 94-102. 10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I. M., Chen A., Zheng Y., Kosaras B., Tsiftsoglou S. A., Vartanian T. K., Brown R. H. and Carroll M. C. (2008). T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA 105, 17913-17918. 10.1073/pnas.0804610105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Pesaresi M. G., Gerbino V., Grosskreutz J. and Carr&#xec; M. T. (2012). Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid Redox Signal. 17, 1277-1330. 10.1089/ars.2011.4328</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.4328</ArticleId><ArticleId IdType="pubmed">22413952</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miranda B. R., Popichak K. A., Hammond S. L., Jorgensen B. A., Phillips A. T., Safe S. and Tjalkens R. B. (2015). The Nurr1 activator 1,1-Bis(3&#x2032;-Indolyl)-1-(p-Chlorophenyl)methane blocks inflammatory gene expression in BV-2 microglial cells by inhibiting nuclear factor &#x3ba;B. Mol. Pharmacol. 87, 1021-1034. 10.1124/mol.114.095398</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.114.095398</ArticleId><ArticleId IdType="pmc">PMC4429718</ArticleId><ArticleId IdType="pubmed">25858541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A. J., Sendtner M. and Shaw P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. 10.1038/nrneurol.2011.152</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Formisano L., Guida N., Valsecchi V., Cantile M., Cuomo O., Vinciguerra A., Laudati G., Pignataro G., Sirabella R., Di Renzo G. et al. (2015). Sp3/REST/HDAC1/hdac2 complex represses and Sp1/HIF-1/p300 complex activates ncx1 gene transcription, in brain ischemia and in ischemic brain preconditioning, by epigenetic mechanism. J. Neurosci. 35, 7332-7348. 10.1523/JNEUROSCI.2174-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2174-14.2015</ArticleId><ArticleId IdType="pmc">PMC6705442</ArticleId><ArticleId IdType="pubmed">25972164</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-P&#xe9;rez D., S&#xe1;ez-Belmonte F., Laorden M. L., N&#xfa;&#xf1;ez C. and Milan&#xe9;s M. V. (2013). Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function. Br. J. Pharmacol. 168, 1889-1901. 10.1111/bph.12083</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12083</ArticleId><ArticleId IdType="pmc">PMC3623059</ArticleId><ArticleId IdType="pubmed">23215787</ArticleId></ArticleIdList></Reference><Reference><Citation>Guglielmotto M., Monteleone D., Piras A., Valsecchi V., Tropiano M., Ariano S., Fornaro M., Vercelli A., Puyal J., Arancio O. et al. (2014). A&#x3b2;1-42 monomers or oligomers have different effects on autophagy and apoptosis. Autophagy 10, 1827-1843. 10.4161/auto.30001</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.30001</ArticleId><ArticleId IdType="pmc">PMC4198366</ArticleId><ArticleId IdType="pubmed">25136804</ArticleId></ArticleIdList></Reference><Reference><Citation>Guida N., Laudati G., Mascolo L., Valsecchi V., Sirabella R., Selleri C., Di Renzo G., Canzoniero L. M. T. and Formisano L. (2017). p38/Sp1/Sp4/HDAC4/BDNF axis is a novel molecular pathway of the neurotoxic effect of the methylmercury. Front. Neurosci. 11, 8 10.3389/fnins.2017.00008</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00008</ArticleId><ArticleId IdType="pmc">PMC5243805</ArticleId><ArticleId IdType="pubmed">28154524</ArticleId></ArticleIdList></Reference><Reference><Citation>Guida N., Valsecchi V., Laudati G., Serani A., Mascolo L., Molinaro P., Montuori P., Di Renzo G., Canzoniero L. M. and Formisano L. (2018). The miR206-JunD circuit mediates the neurotoxic effect of methylmercury in cortical neurons. Toxicol. Sci. 163, 569-578. 10.1093/toxsci/kfy051</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfy051</ArticleId><ArticleId IdType="pubmed">29522201</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M. E., Pu H., Chiu A., Dal Canto M., Polchow C., Alexander D., Caliendo J., Hentati A., Kwon Y., Deng H. et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775. 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A. M., Hester M. E., Miranda C. J., Meyer K., Braun L., Frakes A., Song S. W., Likhite S., Murtha M. J., Foust K. D. et al. (2011). Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824-828. 10.1038/nbt.1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J. S., Beers D. R., Zhao W. and Appel S. H. (2009). Microglia in ALS: the good, the bad, and the resting. J. Neuroimmune Pharmacol. 4, 389-398. 10.1007/s11481-009-9171-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hering R., Petrovic S., Mietz E.-M., Holzmann C., Berg D., Bauer P., Woitalla D., M&#xfc;ller T., Berger K., Kr&#xfc;ger R. et al. (2004). Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology 62, 1231-1232. 10.1212/01.WNL.0000118285.18383.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000118285.18383.90</ArticleId><ArticleId IdType="pubmed">15079038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten K. G., Beers D. R., Zhao W. and Appel S. H. (2015). Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics 12, 364-375. 10.1007/s13311-014-0329-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0329-3</ArticleId><ArticleId IdType="pmc">PMC4404435</ArticleId><ArticleId IdType="pubmed">25567201</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannello A., Rolla S., Maglione A., Ferrero G., Bardina V., Inaudi I., De Mercanti S., Novelli F., D'antuono L., Cardaropoli S. et al. (2019). Pregnancy epigenetic signature in T helper 17 and T regulatory cells in multiple sclerosis. Front. Immunol. 9, 3075 10.3389/fimmu.2018.03075</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03075</ArticleId><ArticleId IdType="pmc">PMC6331474</ArticleId><ArticleId IdType="pubmed">30671056</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M. and Cleveland D. W. (2009). Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772. 10.1083/jcb.200908164</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhodaei B., Ito T., Joodmardi E., Mattsson B., Rouillard C., Carta M., Muramatsu S.-I., Sumi-Ichinose C., Nomura T., Metzger D. et al. (2009). Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J. Neurosci. 29, 15923-15932. 10.1523/JNEUROSCI.3910-09.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3910-09.2009</ArticleId><ArticleId IdType="pmc">PMC6666174</ArticleId><ArticleId IdType="pubmed">20016108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhodaei B., Alvarsson A., Schintu N., Ramskold D., Volakakis N., Joodmardi E., Yoshitake T., Kehr J., Decressac M., Bjorklund A. et al. (2013). Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proc. Natl. Acad. Sci. USA 110, 2360-2365. 10.1073/pnas.1221077110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1221077110</ArticleId><ArticleId IdType="pmc">PMC3568335</ArticleId><ArticleId IdType="pubmed">23341612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.-H., Tang Z., Shimada M., Fierz B., Houck-Loomis B., Bar-Dagen M., Lee S., Lee S.-K., Muir T. W., Roeder R. G. et al. (2013). Histone H3K27 trimethylation inhibits H3 binding and function of SET1-like H3K4 methyltransferase complexes. Mol. Cell. Biol. 33, 4936-4946. 10.1128/MCB.00601-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00601-13</ArticleId><ArticleId IdType="pmc">PMC3889540</ArticleId><ArticleId IdType="pubmed">24126056</ArticleId></ArticleIdList></Reference><Reference><Citation>Le W. D., Xu P., Jankovic J., Jiang H., Appel S. H., Smith R. G. and Vassilatis D. K. (2003). Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 33, 85-89. 10.1038/ng1066</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1066</ArticleId><ArticleId IdType="pubmed">12496759</ArticleId></ArticleIdList></Reference><Reference><Citation>Le W., Pan T., Huang M., Xu P., Xie W., Zhu W., Zhang X., Deng H. and Jankovic J. (2008). Decreased NURR1 gene expression in patients with Parkinson's disease. J. Neurol. Sci. 273, 29-33. 10.1016/j.jns.2008.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.06.007</ArticleId><ArticleId IdType="pmc">PMC2572302</ArticleId><ArticleId IdType="pubmed">18684475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-W., Terranova C., Birkaya B., Narla S., Kehoe D., Parikh A., Dong S., Ratzka A., Brinkmann H., Aletta J. M. et al. (2012). A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. J. Cell. Biochem. 113, 2920-2936. 10.1002/jcb.24170</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.24170</ArticleId><ArticleId IdType="pubmed">22539306</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Wei L., Tao Q., Deng H., Ming M., Xu P. and Le W. (2012). Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease. Eur. J. Neurol. 19, 870-875. 10.1111/j.1468-1331.2011.03644.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03644.x</ArticleId><ArticleId IdType="pubmed">22309633</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Liu H., Li T., Cui J., Fu Y., Ren J., Sun X., Jiang P., Yu S. and Li C. (2017). NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis. Neurosci. Lett. 650, 25-32. 10.1016/j.neulet.2017.01.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.01.062</ArticleId><ArticleId IdType="pubmed">28385514</ArticleId></ArticleIdList></Reference><Reference><Citation>Maira M., Martens C., Philips A. and Drouin J. (1999). Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol. 19, 7549-7557. 10.1128/MCB.19.11.7549</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.11.7549</ArticleId><ArticleId IdType="pmc">PMC84765</ArticleId><ArticleId IdType="pubmed">10523643</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccauley M. E. and Baloh R. H. (2019). Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 137, 715-730. 10.1007/s00401-018-1933-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccombe P. A. and Henderson R. D. (2011). The Role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med. 11, 246-254. 10.2174/156652411795243450</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcmorrow J. P. and Murphy E. P. (2011). Inflammation: a role for NR4A orphan nuclear receptors? Biochem. Soc. Trans. 39, 688-693. 10.1042/BST0390688</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0390688</ArticleId><ArticleId IdType="pubmed">21428963</ArticleId></ArticleIdList></Reference><Reference><Citation>Montarolo F., Raffaele C., Perga S., Martire S., Finardi A., Furlan R., Hintermann S. and Bertolotto A. (2014). Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice. PLoS ONE 9, e108791 10.1371/journal.pone.0108791</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108791</ArticleId><ArticleId IdType="pmc">PMC4181297</ArticleId><ArticleId IdType="pubmed">25265488</ArticleId></ArticleIdList></Reference><Reference><Citation>Montarolo F., Perga S., Martire S. and Bertolotto A. (2015). Nurr1 reduction influences the onset of chronic EAE in mice. Inflamm. Res. 64, 841-844. 10.1007/s00011-015-0871-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-015-0871-4</ArticleId><ArticleId IdType="pubmed">26337347</ArticleId></ArticleIdList></Reference><Reference><Citation>Montarolo F., Perga S., Martire S., Navone D. N., Marchet A., Leotta D. and Bertolotto A. (2016). Altered NR4A subfamily gene expression level in peripheral blood of Parkinson's and Alzheimer's disease patients. Neurotox. Res. 30, 338-344. 10.1007/s12640-016-9626-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-016-9626-4</ArticleId><ArticleId IdType="pubmed">27159982</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B. J., Bender D. E., Segal B. M. and Feldman E. L. (2015). The dual roles of immunity in ALS: injury overrides protection. Neurobiol. Dis. 77, 1-12. 10.1016/j.nbd.2015.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.017</ArticleId><ArticleId IdType="pubmed">25726748</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B. J., Zhou T., Kashlan S. R., Little R. J., Goutman S. A. and Feldman E. L. (2017). Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol 74, 1446-1454. 10.1001/jamaneurol.2017.2255</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P. and Brown R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723. 10.1038/nrn1971</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras A., Schiaffino L., Boido M., Valsecchi V., Guglielmotto M., De Amicis E., Puyal J., Garcera A., Tamagno E., Soler R. M. et al. (2017). Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy. Cell Death Dis. 8, 3223 10.1038/s41419-017-0086-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0086-4</ArticleId><ArticleId IdType="pmc">PMC5870600</ArticleId><ArticleId IdType="pubmed">29259166</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Chi&#xf2; A. and Traynor B. J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17-23. 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W. and Philips T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264. 10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Calvo R., Tajes M. and V&#xe1;zquez-Carrera M. (2017). The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases. Expert Opin Ther. Targets 21, 291-304. 10.1080/14728222.2017.1279146</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2017.1279146</ArticleId><ArticleId IdType="pubmed">28055275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-S&#xe1;nchez E., Yescas P., Rodr&#xed;guez-Violante M., Mart&#xed;nez-Rodr&#xed;guez N., D&#xed;az-L&#xf3;pez J. N., Ochoa A., Valdes-Rojas S. S., Magos-Rodr&#xed;guez D., Rojas-Casta&#xf1;eda J. C., Cervantes-Arriaga A. et al. (2017). Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population. J. Neurol. Sci. 379, 58-63. 10.1016/j.jns.2017.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.05.029</ArticleId><ArticleId IdType="pubmed">28716280</ArticleId></ArticleIdList></Reference><Reference><Citation>Safe S., Jin U.-H., Morpurgo B., Abudayyeh A., Singh M. and Tjalkens R. B. (2016). Nuclear receptor 4A (NR4A) family - orphans no more. J. Steroid Biochem. Mol. Biol. 157, 48-60. 10.1016/j.jsbmb.2015.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2015.04.016</ArticleId><ArticleId IdType="pmc">PMC4618773</ArticleId><ArticleId IdType="pubmed">25917081</ArticleId></ArticleIdList></Reference><Reference><Citation>Saijo K., Winner B., Carson C. T., Collier J. G., Boyer L., Rosenfeld M. G., Gage F. H. and Glass C. K. (2009). A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59. 10.1016/j.cell.2009.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.01.038</ArticleId><ArticleId IdType="pmc">PMC2754279</ArticleId><ArticleId IdType="pubmed">19345186</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini A., Mahajan S. and Gupta P. (2016). Nuclear receptor expression atlas in BMDCs: Nr4a2 restricts immunogenicity of BMDCs and impedes EAE. Eur. J. Immunol. 46, 1842-1853. 10.1002/eji.201546229</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201546229</ArticleId><ArticleId IdType="pubmed">27184189</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucedo-Cardenas O., Quintana-Hau J. D., Le W.-D., Smidt M. P., Cox J. J., De Mayo F., Burbach J. P. H. and Conneely O. M. (1998). Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 4013-4018. 10.1073/pnas.95.7.4013</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.7.4013</ArticleId><ArticleId IdType="pmc">PMC19954</ArticleId><ArticleId IdType="pubmed">9520484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiya T., Kashiwagi I., Inoue N., Morita R., Hori S., Waldmann H., Rudensky A. Y., Ichinose H., Metzger D., Chambon P. et al. (2011). The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat. Commun. 2, 269 10.1038/ncomms1272</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1272</ArticleId><ArticleId IdType="pmc">PMC3104557</ArticleId><ArticleId IdType="pubmed">21468021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiya T., Kashiwagi I., Yoshida R., Fukaya T., Morita R., Kimura A., Ichinose H., Metzger D., Chambon P. and Yoshimura A. (2013). Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat. Immunol. 14, 230-237. 10.1038/ni.2520</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2520</ArticleId><ArticleId IdType="pubmed">23334790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirabella R., Valsecchi V., Anzilotti S., Cuomo O., Vinciguerra A., Cepparulo P., Brancaccio P., Guida N., Blondeau N., Canzoniero L. M. T. et al. (2018). Ionic homeostasis maintenance in ALS: focus on new therapeutic targets. Front. Neurosci. 12, 510 10.3389/fnins.2018.00510</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00510</ArticleId><ArticleId IdType="pmc">PMC6090999</ArticleId><ArticleId IdType="pubmed">30131665</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisalli M. J., Secondo A., Esposito A., Valsecchi V., Savoia C., Di Renzo G. F., Annunziato L. and Scorziello A. (2014). Endoplasmic reticulum refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for neuroprotection. Cell Death Differ. 21, 1142-1149. 10.1038/cdd.2014.32</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.32</ArticleId><ArticleId IdType="pmc">PMC4207481</ArticleId><ArticleId IdType="pubmed">24632945</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff J. R., Simpson E. P. and Appel S. H. (2018). Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr. Opin. Neurol. 31, 635-639. 10.1097/WCO.0000000000000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Troost D., Van den Oord J. J. and Vianney de Jong J. M. (1990). Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 16, 401-410. 10.1111/j.1365-2990.1990.tb01276.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1990.tb01276.x</ArticleId><ArticleId IdType="pubmed">2263315</ArticleId></ArticleIdList></Reference><Reference><Citation>Valsecchi V., Pignataro, G., Sirabella R., Matrone C., Boscia F., Scorziello A., Sisalli M. J., Esposito E., Zambrano N., Cataldi M. et al. (2013). Transcriptional regulation of ncx1 gene in the brain. Adv. Exp. Med. Biol. 961, 137-145. 10.1007/978-1-4614-4756-6_12</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-4756-6_12</ArticleId><ArticleId IdType="pubmed">23224876</ArticleId></ArticleIdList></Reference><Reference><Citation>Valsecchi V., Boido M., De Amicis E., Piras A. and Vercelli A. (2015). Expression of muscle-specific MiRNA 206 in the progression of disease in a murine SMA Model. PLoS ONE 10, e0128560 10.1371/journal.pone.0128560</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128560</ArticleId><ArticleId IdType="pmc">PMC4450876</ArticleId><ArticleId IdType="pubmed">26030275</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercelli A., Mereuta O. M., Garbossa D., Muraca G., Mareschi K., Rustichelli D., Ferrero I., Mazzini L., Madon E. and Fagioli F. (2008). Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 31, 395-405. 10.1016/j.nbd.2008.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.05.016</ArticleId><ArticleId IdType="pubmed">18586098</ArticleId></ArticleIdList></Reference><Reference><Citation>Volakakis N., Kadkhodaei B., Joodmardi E., Wallis K., Panman L., Silvaggi J., Spiegelman B. M. and Perlmann T. (2010). NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection. Proc. Natl. Acad. Sci. USA 107, 12317-12322. 10.1073/pnas.1007088107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007088107</ArticleId><ArticleId IdType="pmc">PMC2901488</ArticleId><ArticleId IdType="pubmed">20566846</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N. P. C. and Perlmann T. (2003). Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423, 555-560. 10.1038/nature01645</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01645</ArticleId><ArticleId IdType="pubmed">12774125</ArticleId></ArticleIdList></Reference><Reference><Citation>Won H. Y. and Hwang E. S. (2016). Transcriptional modulation of regulatory T cell development by novel regulators NR4As. Arch. Pharm. Res. 39, 1530-1536. 10.1007/s12272-016-0803-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-016-0803-z</ArticleId><ArticleId IdType="pubmed">27778276</ArticleId></ArticleIdList></Reference><Reference><Citation>Worms P. M. (2001). The epidemiology of motor neuron diseases: a review of recent studies. J. Neurol. Sci. 191, 3-9. 10.1016/S0022-510X(01)00630-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00630-X</ArticleId><ArticleId IdType="pubmed">11676986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m R. H., Solomin L., Jansson L., Hoffer B. J., Olson L. and Perlmann T. (1997). Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248-250. 10.1126/science.276.5310.248</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.276.5310.248</ArticleId><ArticleId IdType="pubmed">9092472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Gascon R., Miller R. G., Gelinas D. F., Mass J., Hadlock K., Jin X., Reis J., Narvaez A. and Mcgrath M. S. (2005). Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 159, 215-224. 10.1016/j.jneuroim.2004.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.10.009</ArticleId><ArticleId IdType="pubmed">15652422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D. R. and Appel S. H. (2013). Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmune Pharmacol. 8, 888-899. 10.1007/s11481-013-9489-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Su P., Li D., Tsang S., Duan E. and Wang F. (2010). High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28, 1741-1750. 10.1002/stem.504</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.504</ArticleId><ArticleId IdType="pmc">PMC3322377</ArticleId><ArticleId IdType="pubmed">20734356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>